BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Policy

  House Passes Transparency Reforms to Medicare’s Local Coverage Program

  The House of Representatives passed the Local Coverage Determination Clarification Act, which aims to improve accountability and transparency in the process Medicare contractors use to make local coverage decisions. The legislation passed the House by a voice vote on September 12.

  September 12, 2018

   · 

  2 min read
• Drug Development

  Novartis announces NEJM publication of landmark PARADIGMS study demonstrating significant benefit of Gilenya® in children and adolescents with relapsing multiple sclerosis

  Novartis today announced that The New England Journal of Medicine (NEJM) has published full results from the landmark Phase III Gilenya® (fingolimod) PARADIGMS study,

  September 12, 2018

   · 

  15 min read
• Job Trends

  Surefire Medical to Change Name to TriSalus Life Sciences

  Surefire Medical, Inc., (Surefire) announced today the company is changing its name to TriSalus Life Sciences to better reflect the company’s contribution to patient care.

  September 12, 2018

   · 

  2 min read
• Policy

  Quanterix Announces Termination of License Agreement with bioMérieux

  Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the consolidation of its licensing position and reestablishment of control of its intellectual property in the in vitro diagnostics (IVD) field.

  September 12, 2018

   · 

  3 min read
• Policy

  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY

  Pomerantz LLP is investigating claims on behalf of investors of Alnylam Pharmaceuticals, Inc.

  September 12, 2018

   · 

  2 min read
• Business

  BioPharmX Corporation Announces David S. Tierney, M.D. Joined the Company as Chief Executive Officer

  BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced the appointment of David S. Tierney, M.D., as its chief executive officer.

  September 12, 2018

   · 

  4 min read
• Policy

  OPKO Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against OPKO Health, Inc. - OPK

  Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of OPKO Health, Inc.

  September 12, 2018

   · 

  4 min read
• CathWorks FFRangio™ System Clinical Review Featured in TCT 2018 Program

  he CathWorks FFRangio™ System will be featured in a TCT Lunch Presentation Theater Program held during the 2018 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting in San Diego.

  September 12, 2018

   · 

  2 min read
• Haier Biomedical saves lives by moving the blood bank right beside the patient

  The laboratory equipment manufacturer’s Rendanheyi management model empowers the transformation of the biotechnology ecosystem

  September 12, 2018

   · 

  4 min read
• Duchesnay Inc. to Present a Poster on the Efficacy and Safety of Ospemifene in Menopausal Women with Moderate to Severe Vaginal Dryness at 2018 Annual Meeting of the North American Menopause Society (NAMS)

  Duchesnay Inc. announced today that it will present a poster on the topic of ospemifene at the 2018 Annual Meeting of the North American Menopause Society (NAMS) in San Diego.

  September 12, 2018

   · 

  2 min read